文献速递妇科

磁共振ADNEX评分系统评估附件肿块:弥散加权成像及ADC图的附加价值

Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该前瞻性研究纳入323例经阴道超声诊断附件肿块的女性,其中131例后续手术,手术证实161个肿块(47个恶性/交界性,114个良性)。经典ADNEX MR评分AUC为0.938,整合DWI及ADC图的改良评分AUC为0.974,两者差异有统计学意义(P=0.0032)。改良评分在评分≥4时诊断恶性的特异度从86.6%提高至93.3%。

要点

  • 改良ADNEX MR评分整合DWI及ADC图可提高诊断恶性附件肿块的AUC(0.974 vs 0.938,P=0.0032)。
  • 评分≥4时,改良评分特异度93.3%高于经典评分86.6%,敏感度相近(95.7% vs 95.5%)。
  • DWI及ADC图整合有望优化临床管理,避免不必要的手术。

核心结论

  • DWI及ADC图可整合入ADNEX MR评分系统以提高特异度。

研究设计与样本

  • 前瞻性研究,2015年1月至2018年9月连续纳入323例经阴道超声诊断附件肿块的女性,均行标准化MRI(含弥散及动态增强序列),其中131例后续手术。
  • 以组织学诊断为金标准,将病变分类为良性或恶性(交界性肿瘤归入恶性组)。

主要发现

  • 手术证实161个附件肿块(32个恶性肿瘤、15个交界性肿瘤归为恶性组共47个、114个良性),所有肿块均被MRI检出。
  • 经典ADNEX MR评分预测恶性的AUC为0.938(95%CI,0.902-0.975),改良评分AUC为0.974(95%CI,0.953-0.996),两者比较P=0.0032。
  • ADNEX MR评分≥4诊断恶性的敏感度和特异度:经典评分分别为95.5%和86.6%,改良评分分别为95.7%和93.3%。

关键数值与推荐

  • ADNEX MR评分≥4诊断恶性的敏感度95.5%、特异度86.6%(经典评分)。
  • ADNEX MR评分≥4诊断恶性的敏感度95.7%、特异度93.3%(改良评分,整合DWI及ADC图)。

临床怎么用

  • 在ADNEX MR评分中整合DWI及ADC图可提高诊断恶性附件肿块的特异度,可能避免不必要的手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To validate prospectively the ADNEX magnetic resonance (MR) scoring system to assess adnexal masses and to evaluate a new, modified ADNEX MR scoring system that incorporates diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping. METHODS: Between January 2015 and September 2018, 323 consecutive women with adnexal masses diagnosed on transvaginal ultrasound (TVS) underwent standardized MR imaging (MRI) including diffusion and dynamic contrast-enhanced sequences. Of these, 131 underwent subsequent surgery. For interpretation of the MRI examinations, we applied the five-category ADNEX MR scoring system, along with a modified scoring system including DWI with ADC mapping. For both scoring systems, a score was given for all adnexal masses. Histological diagnosis was considered as the gold standard and lesions were classified as benign or malignant. The difference between the predictive values for diagnosing malignancy of the classical and modified scoring systems was assessed on the basis of the areas under the receiver-operating-characteristics (AUC) curves. The sensitivity and specificity for diagnosing malignancy of each score were also calculated. RESULTS: Among the 131 women with adnexal mass(es) diagnosed on TVS who underwent MRI and subsequent surgery, the surgery revealed 161 adnexal masses in 126 women; five women had no mass. Histological examination confirmed 161 adnexal masses, of which all had been detected on MRI: 32 malignant tumors, 15 borderline tumors, which were classified as part of the malignant group (n = 47), and 114 benign lesions. The AUC for prediction of a malignant lesion was 0.938 (95% CI, 0.902-0.975) using the classical ADNEX MR scoring system and 0.974 (95% CI, 0.953-0.996) using the modified scoring system. Pairwise comparison of these AUCs revealed a significant difference (P = 0.0032). The sensitivity and specificity for diagnosing malignancy with an ADNEX MR score of 4 or more were 95.5% and 86.6%, respectively, using the classic scoring system, and 95.7% and 93.3%, respectively, using the modified scoring system. CONCLUSION: DWI with ADC mapping could be integrated into the ADNEX MR scoring system to improve specificity, thereby potentially optimizing clinical management by avoiding unnecessary surgery. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hottat NA, Van Pachterbeke C, Vanden Houte K, et al. Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map. Ultrasound Obstet Gynecol. 2021. PMID: 32438461. doi:10.1002/uog.22090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。